skip to main content
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search prefilters

Role of 5-HT1A and 5-HT2C receptors of the dorsal periaqueductal gray in the anxiety- and panic-modulating effects of antidepressants in rats

Vilela-Costa, Heloisa H. ; Maraschin, Jhonatan Christian ; Casarotto, Plinio C. ; Sant’Ana, Ana Beatriz ; de Bortoli, Valquiria C. ; Vicente, Maria Adrielle ; Campos, Alline Cristina ; Guimarães, Francisco S. ; Zangrossi, Helio

Behavioural brain research, 2021-04, Vol.404, p.113159-113159, Article 113159 [Periódico revisado por pares]

Elsevier B.V

Texto completo disponível

Citações Citado por
  • Título:
    Role of 5-HT1A and 5-HT2C receptors of the dorsal periaqueductal gray in the anxiety- and panic-modulating effects of antidepressants in rats
  • Autor: Vilela-Costa, Heloisa H. ; Maraschin, Jhonatan Christian ; Casarotto, Plinio C. ; Sant’Ana, Ana Beatriz ; de Bortoli, Valquiria C. ; Vicente, Maria Adrielle ; Campos, Alline Cristina ; Guimarães, Francisco S. ; Zangrossi, Helio
  • Assuntos: Anxiety ; Dorsal periaqueductal gray ; Fluoxetine ; Imipramine ; Panic ; Serotonin
  • É parte de: Behavioural brain research, 2021-04, Vol.404, p.113159-113159, Article 113159
  • Notas: ObjectType-Article-1
    SourceType-Scholarly Journals-1
    ObjectType-Feature-2
    content type line 23
  • Descrição: •dPAG 5-HT1A receptors are recruited for the panicolytic effect of chronic imipramine.•Chronic fluoxetine or imipramine does not change 5-HT1A receptor levels in the dPAG.•dPAG 5-HT2C receptors does not mediate the acute anxiogenic effect of antidepressants. Antidepressant drugs are first-line treatment for panic disorder. Facilitation of 5-HT1A receptor-mediated neurotransmission in the dorsal periaqueductal gray (dPAG), a key panic-associated area, has been implicated in the panicolytic effect of the selective serotonin reuptake inhibitor fluoxetine. However, it is still unknown whether this mechanism accounts for the antipanic effect of other classes of antidepressants drugs (ADs) and whether the 5-HT interaction with 5-HT2C receptors in this midbrain area (which increases anxiety) is implicated in the anxiogenic effect caused by short-term treatment with ADs. The results showed that previous injection of the 5-HT1A receptor antagonist WAY-100635 in the dPAG blocked the panicolytic-like effect caused by chronic systemic administration of the tricyclic AD imipramine in male Wistar rats tested in the elevated T-maze. Neither chronic treatment with imipramine nor fluoxetine changed the expression of 5-HT1A receptors in the dPAG. Treatment with these ADs also failed to significantly change ERK1/2 (extracellular-signal regulated kinase) phosphorylation level in this midbrain area. Blockade of 5-HT2C receptors in the dPAG with the 5-HT2C receptor antagonist SB-242084 did not change the anxiogenic effect caused by a single acute injection of fluoxetine or imipramine in the Vogel conflict test. These results reinforce the view that the facilitation of 5-HT1A receptor-mediated neurotransmission in the dPAG is a common mechanism involved in the panicolytic effect caused by chronic administration of ADs. On the other hand, the anxiogenic effect observed after short-term treatment with these drugs does not depend on 5-HT2C receptors located in the dPAG.
  • Editor: Elsevier B.V
  • Idioma: Inglês

Buscando em bases de dados remotas. Favor aguardar.